BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36897521)

  • 1. A Bioequivalence Study of Ezetimibe/Rosuvastatin Fixed Dose Combination (10 mg/10 mg) Versus the Individual Formulations Taken Concomitantly.
    Di Y; Wang Z; Jia C; Xie X; Yang S; Wang W; Xie X; Wang Q; Hu C; Xie F; Abdel-Moneim M; Hovsepian L; Wu Y; Yang N; Hou J
    Adv Ther; 2023 May; 40(5):2205-2216. PubMed ID: 36897521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects
.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Na S; Kim HJ; Yoon YR; Lee HW
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):43-52. PubMed ID: 29162214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
    Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
    BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects.
    Min KL; Park MS; Jung J; Chang MJ; Kim CO
    Clin Ther; 2017 Sep; 39(9):1799-1810. PubMed ID: 28803122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Interactions and Tolerability of Rosuvastatin and Ezetimibe: A Randomized, Phase 1, Crossover Study in Healthy Chinese Participants.
    Wang L; Luan Y; Jia C; Xie X; Zhang Z; Xie X; Wang Q; Hu C; Xie F; Abdel-Moneim M; Hovsepian L; Zhao Z; Yang N; Hou J
    Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):51-62. PubMed ID: 36437383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single-dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions.
    Zhu KW; Wang GM; Li CY; Liu JY; Huang JY; Wu JR; Song WJ; Deng J; Wang JS; Qin F
    Clin Pharmacol Drug Dev; 2022 Aug; 11(8):987-996. PubMed ID: 35567420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
    Li Q; Hao Z; Yu Y; Tang Y
    Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
    Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
    Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
    Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
    Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
    Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
    BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
    Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
    Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies.
    Atrux-Tallau N; Naimi Z; Jaudinot EO
    Clin Drug Investig; 2022 Dec; 42(12):1101-1112. PubMed ID: 36331670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
    Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
    Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
    Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
    Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
    Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, crossover study to determine bioequivalence of two brands of dexibuprofen 400 mg tablets in healthy Asian adult male subjects of Indian origin.
    Menon S; Kadam N; Patil G; Mhatre P
    Int J Clin Pharmacol Ther; 2008 Jan; 46(1):48-54. PubMed ID: 18218298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
    Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
    Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male Volunteers.
    Luo Z; Nan F; Miao J; Chen Z; Li M; Liang M
    PLoS One; 2016; 11(3):e0150661. PubMed ID: 26974539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.